Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP 36 Net Margin % is 24,100.00% as of Dec. 2025, which is 22% below its 10-year median of 30,900.00. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 119 Medical Distribution companies, BMP Pharma Trading AG ranks better than 99.16% on this metric.
BMP Pharma Trading AG (STU:BMP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
BMP Pharma Trading AG Net Margin % Related Terms
BMP Pharma Trading AG Net Margin % Historical Data
* Premium members only.
The historical data trend for BMP Pharma Trading AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, BMP Pharma Trading AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMP Pharma Trading AG (STU:BMP) has a Net Margin % of 24,100.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on BMP Pharma Trading AG and its competitors. This is 22% below median its historical median of 30,900.00. According to the industry distribution chart, BMP Pharma Trading AG ranks #1 out of 119 companies in the Medical Distribution industry, placing it in the top 0.8%.
Is BMP Pharma Trading AG's Net Margin % too high?
BMP Pharma Trading AG's current Net Margin % of 24,100.00% is 22% below median its 10-year median of 30,900.00. The Medical Distribution industry median Net Margin % is 1.38. BMP Pharma Trading AG's value of 24,100.00% is 1746276.8% above this industry median. Based on the distribution chart, BMP Pharma Trading AG ranks #1 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #1 out of 119 companies for Net Margin %. This places BMP Pharma Trading AG in the top 1% of its industry — outperforming the majority of peers. The industry median Net Margin % is 1.38. BMP Pharma Trading AG's value of 24,100.00% is 1746276.8% above this benchmark. While the company's 10-year median is 30,900.00 vs. the industry median of 1.38, BMP Pharma Trading AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.38, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BMP Pharma Trading AG's current Net Margin % of 24,100.00% is 1746276.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current Net Margin % is 24,100.00%, which is 22% below median its own 10-year median of 30,900.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Net Margin % of 24,100.00%. The current Net Margin % is 24,100.00%, which is 22% below median its 10-year median of 30,900.00 and 1746276.8% above the Medical Distribution industry median of 1.38. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Net Margin % is 24,100.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
